340B “Mega-Guidance” Delayed To December (Or Beyond)

HRSA official stresses importance “good faith” by manufacturers and purchasers to assure program integrity while key definitions remain in limbo.

The HHS Health Resources & Services Administration is now working towards a December deadline to issue a final guidance on the 340B program, Office of Pharmacy Affairs Director Krista Pedley told the 340B Coalition annual summer conference on July 11.

HRSA issued the draft “mega-guidance” defining many key components of the 340B drug discount program in August 2015. (Also see...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet